Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
Titel:
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
Auteur:
van Kempen, Z.L.E. Wieske, L. Stalman, E.W. Kummer, L. Y. L van Dam, P.J. Volkers, A.G. Boekel, L. Toorop, A.A. Strijbis, E.M.M. Tas, S.W. Wolbink, G.J. Löwenberg, M. van Sandt, C. ten Brinke, A. Verstegen, N.J.M. Steenhuis, M. Kuijpers, T.W. van Ham, S.M. Rispens, T. Eftimov, F. Killestein, J.